10Elms LLP’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
10Elms LLP's BMY Position: Q2 2026 in Review
10Elms LLP opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 504 shares worth $29K. The stake represents 0.01% of the portfolio and ranks #323 among its holdings. This is a return to the name: 10Elms LLP previously reported a position in BMY as recently as Q1 2025.
10Elms LLP first reported a position in BMY in Q4 2024 and has held it in 3 quarters since. The position peaked at $92.3K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- 10Elms LLP held 504 shares of Bristol-Myers Squibb worth $29K as of Q2 2026.
- Bristol-Myers Squibb was a new 10Elms LLP position in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of 10Elms LLP's portfolio in Q2 2026, its #323 holding.
- 10Elms LLP first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 3 quarters since.
- 10Elms LLP's Bristol-Myers Squibb position peaked at $92.3K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.